Joseph E. Payne

Insider Reports History

Entity
Individual
Location
10628 Science Center Drive, Suite 200, San Diego, CA
Signature
/s/ Ilan Katz, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph E. Payne:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcturus Therapeutics Holdings Inc. President and CEO, Director Employee Stock Option (right to buy) 200K Dec 15, 2023 Direct
Arcturus Therapeutics Holdings Inc. President and CEO, Director Employee Stock Option (right to buy) 196K Dec 16, 2024 Direct
Vallon Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 7.5K Jun 9, 2022 Direct

Insider Reports Filed by Joseph E. Payne

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARCT Arcturus Therapeutics Holdings Inc. Dec 16, 2024 1 $0 4 Dec 18, 2024 President and CEO, Director
ARCT Arcturus Therapeutics Holdings Inc. Dec 15, 2023 1 $0 4 Dec 19, 2023 President and CEO, Director
ARCT Arcturus Therapeutics Holdings Inc. Dec 9, 2022 1 $0 4 Dec 13, 2022 President and CEO, Director
ARCT Arcturus Therapeutics Holdings Inc. Nov 23, 2022 1 $82.6K 4 Nov 28, 2022 President and CEO, Director
ARCT Arcturus Therapeutics Holdings Inc. Jun 21, 2022 1 $0 4 Jun 23, 2022 President and CEO, Director
GRI Vallon Pharmaceuticals, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
GRI Vallon Pharmaceuticals, Inc. May 25, 2021 2 $71.8K 4 May 27, 2021 Director
GRI Vallon Pharmaceuticals, Inc. May 14, 2021 2 $0 4 May 18, 2021 Director